MRC1 and colorectal carcinoma: Our findings are not only consistent with a previous notion that MMR mutations represent early events in CRC carcinogenesis, but also suggest that perturbation of TGFβ signaling through truncating mutations in ACVR2A and TGBFR2 might be early events during this process.